{"title":"[Hypertrophy of the lumbosacral nerve roots in Noonan syndrome with multiple lentigines: a case report].","authors":"Yukako Araga, Yoshitsugu Nakamura, Kensuke Kakiuchi, Takafumi Hosokawa, Shimon Ishida, Shigeki Arawaka","doi":"10.5692/clinicalneurol.cn-002094","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002094","url":null,"abstract":"<p><p>The patient was a 61-year-old man in whom sensorineural hearing loss were noted after birth and the presence of multiple cutaneous millet-sized lentigines were noted after about 6-year-old. He had pain in his bilateral lower extremities; 1 month later, he visited our hospital. He had no family history of neurological or cutaneous symptoms. In nerve conduction studies, the F-wave frequencies were reduced in the bilateral tibial nerves. In lumbar spine magnetic resonance imaging, the bilateral lumbosacral nerve roots showed hypertrophy. A genetic analysis revealed that he had a heterozygous single-base non-synonymous substitution in the PTPN11 gene (c.1403C>T, p.Thr468Met). This substitution is known pathogenic variant. We diagnosed the patient with Noonan syndrome with multiple lentigines. This syndrome is a RASopathy that is caused by variants in genes encoding the SHP-2 protein, which is a component of the RAS/mitogen-activated protein kinase (MAPK) signaling pathway. RASopathies should be included as differential diagnoses for spinal nerve root enlargement.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[An autopsy case of non-drug related progressive multifocal leukoencephalopathy in a background of rheumatoid arthritis].","authors":"Yoshie Kato, Asuka Araki, Yoshiharu Miura, Kazuo Nakamichi, Kenta Takahashi, Atsushi Nagai","doi":"10.5692/clinicalneurol.cn-002080","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002080","url":null,"abstract":"<p><p>A 56-year-old male subject was presented with a two-month history of dysarthria and gait disturbance. T<sub>2</sub>-weighted MRI revealed high signal intensity in the right cerebellar hemisphere, pons, and bilateral middle cerebellar peduncles. Suspecting brain-stem encephalitis, he was treated with steroid pulse therapy, which was ineffective. Subsequently, a qualitative PCR test was performed, confirming the diagnosis of progressive multifocal leukoencephalopathy (PML) with a high JC virus (JCV) load (273,857 copies/ml) in the cerebrospinal fluid (CSF). The JCV strain in the CSF was a prototype with a deletion in the regulatory region of its genomic DNA. Long-term untreated rheumatoid arthritis (RA) was identified as an underlying cause. Other potential immunodeficiency-related diseases, including idiopathic CD4 lymphocytopenia, malignant RA, systemic lupus erythematosus, chronic eosinophilic leukemia, malignant lymphoma, and congenital immunodeficiency, were ruled out based on various laboratory tests. Despite treatment with a combination of mefloquine and mirtazapine, the patient died on the 102nd day due to disease progression. RA with non-drug related immune abnormalities should be considered a potential underlying cause of PML.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[A case of recurrent cerebellitis leading to the diagnosis of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)].","authors":"Yuko Ito, Chikako Ochi, Yuki Yamanishi, Hiroshi Takashima, Akihiro Hashiguchi, Masahiro Nagai","doi":"10.5692/clinicalneurol.cn-002117","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002117","url":null,"abstract":"<p><p>The patient was a 41-year-old man with a history of diabetes mellitus since the age of 22 years and a family history of diabetes in his mother. He had repeated headaches, cerebellar symptoms, and bilateral cerebellar lesions on brain MRI (DWI, T<sub>2</sub> FLAIR hyperintensities). He was previously diagnosed with cerebellitis and treated with steroids at another hospital. Upon his third relapse, he was referred to our department. Clinical findings included short stature, diabetes, elevated CSF lactate and pyruvate levels, and increased lactate levels on aerobic exercise testing. Muscle biopsy revealed mitochondrial pathological abnormalities, and genetic testing of muscle tissue identified the mitochondrial DNA m.3243 mutation. These findings led to the diagnosis of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Stroke-like lesions in MELAS can involve not only the cerebrum but also the cerebellum. When cortical-predominant lesions with associated vascular dilatation are observed, MELAS should be considered in the differential diagnosis.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical NeurologyPub Date : 2025-07-24DOI: 10.5692/clinicalneurol.cn-002139
Takashi Kanda
{"title":"[Received the Japan Neurological Society Award].","authors":"Takashi Kanda","doi":"10.5692/clinicalneurol.cn-002139","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002139","url":null,"abstract":"<p><p>I had the honor of being awarded the 2021 Japan Neurological Society Award in the Clinical/Education category. The award theme was 'Efforts in Undergraduate and Specialist Training in Neurology,' and until the previous year, this category had been awarded to those who made significant contributions in clinical practice. This was the first time education had been recognized with an award in this category. It is believed that the publication of 'Neurology for Medical Students and Residents,' first published in 2008, played a crucial role in this honor due to its contribution to undergraduate and postgraduate education. I will discuss the background of the publication, its formation, the philosophy behind its creation, and what it aimed to convey.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical NeurologyPub Date : 2025-07-24DOI: 10.5692/clinicalneurol.cn-002123
Tomoki Ishimaru, Kei Oiwa, Sho Seo, Takahiro Kano, Hideki Hozen
{"title":"[A case of Streptococcus suis meningitis in which the patient suffered sensorineural hearing loss and requring long-term antibacterial treatment].","authors":"Tomoki Ishimaru, Kei Oiwa, Sho Seo, Takahiro Kano, Hideki Hozen","doi":"10.5692/clinicalneurol.cn-002123","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002123","url":null,"abstract":"<p><p>A man in his 40s was transferred to our hospital due to headache, hearing loss, and altered consciousness, which developed several days after consuming a barbeque meal, including pork. Based on his clinical symptoms and various laboratory findings, he was diagnosed with bacterial meningitis caused by Streptococcus suis, and treatment was initiated with antibacterial agents and dexamethasone. After 3 weeks, his symptoms and laboratory results showed improvement, allowing for the discontinuation of the antibacterial therapy. However, a few days after stopping antibiotics, his symptoms and cerebrospinal fluid (CSF) findings worsened, prompting the resumption of antibacterial treatment. The therapy was ultimately terminated after 5 weeks, following confirmation of clinical and CSF improvement. Despite resolution of the meningitis symptoms, the patient was left with bilateral sensorineural hearing loss, predominantly affecting his right ear. Following systemic steroid administration and hyperbaric oxygen therapy, his left-sided hearing improved, but no improvement was observed in his right ear, and he continued to experience severe hearing loss.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical NeurologyPub Date : 2025-07-24DOI: 10.5692/clinicalneurol.cn-002087
Raita Kikuchi, Kenji Ishihara, Jun'ichi Shiota, Mitsuru Kawamura, Mari Yoshida
{"title":"[An autopsy case of spinal bulbar muscular atrophy concomitant with multiple system atrophy pathology].","authors":"Raita Kikuchi, Kenji Ishihara, Jun'ichi Shiota, Mitsuru Kawamura, Mari Yoshida","doi":"10.5692/clinicalneurol.cn-002087","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002087","url":null,"abstract":"<p><p>We describe an autopsy case of spinal bulbar muscular atrophy (SBMA) concomitant with multiple system atrophy (MSA). A Japanese male patient developed gait disturbance in his twenties. His brother and niece also presented with similar clinical symptoms. His condition gradually worsened, and he became immobile at the age of 50 years. Genetic analysis revealed the expansion of CAG repeats of the SBMA gene. At 63 years of age, cerebellar ataxia symptoms emerged. Magnetic resonance images of the head showed a \"hot cross bun sign\" at the pontine basis and bilateral atrophy of the middle cerebellar peduncles and cerebellar hemispheres, suggesting MSA. He died of pneumonia at the age of 65 years, with a clinical illness of approximately 40 years. The neuropathological diagnosis was consistent with both SBMA and MSA. Neurons of the spinal anterior horn and brainstem motor nuclei were diminished. 1C2 (polyglutamine) immunoreactive intranuclear and intracytoplasmic inclusions were observed in the neurons in the substantia nigra, brainstem tegmentum, pontine nuclei, spinal anterior horn cells and Onuf's nucleus. These findings were suggestive of SBMA. Meanwhile, neurons of the inferior olivary nuclei, pontine nuclei, and Purkinje cells were nearly completely lost. The cerebellar white matter, pontine basis, and middle cerebellar peduncles showed a prominent loss of fibers. α-synuclein positive glial cytoplasmic inclusions were observed in widespread areas. These findings were suggestive of MSA. To the best of our knowledge, another case of SBMA accompanying MSA, similar to the present case, have been reported to date. Moreover, several cases of pathologically proven amyotrophic lateral sclerosis and MSA have been reported. The development of molecular biological techniques and accumulation of pathologically diagnosed patients may reveal common pathological mechanisms in SBMA and MSA.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[A case of treatment-related leukoencephalopathy during combination therapy with daratumumab, lenalidomide, and low-dose dexamethasone for multiple myeloma].","authors":"Keiko Maezono-Kandori, Hiroki Suo, Naoki Tokuda, Atsushi Yamamoto, Shiori Ogura, Yoshinari Nagakane","doi":"10.5692/clinicalneurol.cn-002069","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002069","url":null,"abstract":"<p><p>A 75-year-old woman with multiple myeloma was admitted due to an acute disturbance of consciousness and aphasia two months after administration of daratumumab, lenalidomide and dexamethasone combination therapy (DLd therapy). Brain MRI on admission showed no acute ischemic changes. She was treated with antiepileptic drugs, and DLd therapy was discontinued, but her consciousness deteriorated, and follow-up brain MRI showed progressive FLAIR high-signal intensity lesions in the cerebral deep white matter bilaterally. Though methylprednisolone pulse therapy and high-dose intravenous immunoglobulin were ineffective, plasma exchange improved her consciousness, and she began to speak. In addition, her MRI findings improved. Progressive multifocal leukoencephalopathy induced by drugs for multiple myeloma has been reported, but, in this case, leukoencephalopathy associated with daratumumab was suspected because JC virus DNA was not detected in her cerebrospinal fluid.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical NeurologyPub Date : 2025-06-26Epub Date: 2025-05-20DOI: 10.5692/clinicalneurol.cn-002036
Kyoko Maruta, Kazutaka Shiomi
{"title":"[Posterior cortical atrophy presenting with agraphia for kanji and statokinetic dissociation (Riddoch phenomenon): a case report].","authors":"Kyoko Maruta, Kazutaka Shiomi","doi":"10.5692/clinicalneurol.cn-002036","DOIUrl":"10.5692/clinicalneurol.cn-002036","url":null,"abstract":"<p><p>We report a patient with posterior cortical atrophy (PCA) who manifested as agraphia for kanji and statokinetic dissociation (Riddoch phenomenon). A 52-year-old, right-handed woman complained that beginning at age 50, she could write only kana (a phonographic script) but not kanji (a morphographic script). She could not write even her own name in kanji. Neuropsychologic examinations disclosed kanji-dominant agraphia, acalculia, right-left disorientation, finger agnosia, constructional apraxia, and simultanagnosia. Many of these, including agraphia, are components of Gerstmann syndrome. She manifested no aphasia or alexia, while not only writing but also copying of kanji was impaired. Speech functions, behavior, and personality were relatively spared. The patient also displayed statokinetic dissociation (Riddoch phenomenon): kinetic Goldmann fields were normal, but static Humphrey visual fields showed an incongruous right homonymous hemianopsia. MRI showed atrophy of the left parietal lobe. <sup>99m</sup>Tc ethyl cysteinate dimer (ECD) single-photon emission computed tomography (SPECT) showed hypoperfusion , predominantly in the left hemisphere and especially left the parietal lobe . These clinical and neuroradiologic findings are consistent with PCA. In patients with PCA, suspected incomplete homonymous hemianopsia should be confirmed with a Humphrey visual field test. Ishihara pseudoisochromatic plates may not be reliable; color vision should be checked using the panel D-15 test.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":"416-423"},"PeriodicalIF":0.0,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144121047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[A case of young woman with intracranial gumma developed within 1 year after Treponema pallidum infection].","authors":"Takahiro Akamatsu, Yuichi Masuda, Taiki Sawai, Shin Ota, Takafumi Hosokawa, Shigeki Arawaka","doi":"10.5692/clinicalneurol.cn-002073","DOIUrl":"10.5692/clinicalneurol.cn-002073","url":null,"abstract":"<p><p>A 17-years-old woman visited the hospital due to convulsions. T<sub>2</sub>-weighted images showed high intensity areas in right temporal lobe and left frontal lobe. Enhanced T<sub>1</sub>-weighted images showed mass-like lesions on the dura mater. Based on mononuclear pleocytosis and a reactive fluorescent treponemal antibody-absorption test in the cerebrospinal fluid, neurosyphilis and intracranial gumma were diagnosed, and antibiotic therapy was initiated. After treatments, the high intensity areas improved, and she had no recurrence of symptoms or MRI images. Intracranial gumma usually develops in tertiary syphilis, more than 1 year after infection. In this case, intracranial gumma developed within 1 year after infection. Even if the patient is a young woman, it is necessary to consider the possibility of intracranial gumma and select appropriate examinations and treatments earlier.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":"424-428"},"PeriodicalIF":0.0,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144121067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical NeurologyPub Date : 2025-06-26Epub Date: 2025-05-24DOI: 10.5692/clinicalneurol.cn-002102
Satoshi Kamei
{"title":"[Update of clinical management in autoimmune encephalitis-2024].","authors":"Satoshi Kamei","doi":"10.5692/clinicalneurol.cn-002102","DOIUrl":"10.5692/clinicalneurol.cn-002102","url":null,"abstract":"<p><p>Encephalitis is a life-threatening disease with many causes. The continual discovery of newly identified forms of autoimmune encephalitis (AE) associated with antibodies to cell-surface or synaptic proteins has changed the paradigms for diagnosing and treating disorders. AE is one of the most common causes of non-infectious encephalitis. It can be triggered by tumors, infections, or it may be cryptogenic. These disorders can occur in patients with or without cancer. I review here the update of clinical management in AE. Recent clinical trends in AE include 1) the spread of clinical manifestations, 2) pitfalls of misdiagnosed cases and risk factors for misdiagnosis, and 3) treatment trends for refractory cases and symptomatic epilepsy. 1) The spread of clinical manifestations includes the presence of autoimmune psychosis (Pollak TA Lancet Psychiatry 2020), the presence of AE in adult-onset temporal lobe epilepsy (Kuehn JC, PLoS One 2020), and AE cases presenting with progressive dementia (Bastiaansen AEM, Neurol Neuroimmunol Neuroinflamm 2021). 2) Misdiagnosis and inappropriate use of diagnostic criteria for antibody-negative cases have been pointed out (Dalmau J. Lancet Neurol 2023). Misdiagnoses of AE occur for three reasons. First, non-adherence to reported clinical requirements for diagnostic criteria for AE. Second, the evaluation of inflammatory changes in head MRI and cerebrospinal fluid is insufficient. Third, absent or limited use of brain tissue assays along with use of cell-based assays that include only a narrow range of antigens. Red flags suggesting alternative diagnoses included an insidious onset, positive nonspecific serum antibody, and failure to fulfill AE diagnostic criteria. 3) Treatment trends for rituximab-resistant refractory cases include tocilizumab (IL6 receptor monoclonal antibody) and bortezomib (26S proteasome inhibitor). On the other hand, new Na channel inhibitors (lacosamide, etc.) and perampanel may be useful for treating symptomatic epilepsy in AE.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":"409-415"},"PeriodicalIF":0.0,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144121053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}